{"pmid":32389785,"title":"Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19.","text":["Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19.","J Infect","Su, Ying","Tu, Guo-Wei","Ju, Min-Jie","Yu, Shen-Ji","Zheng, Ji-Li","Ma, Guo-Guang","Liu, Kai","Ma, Jie-Fei","Yu, Kai-Huan","Xue, Yuan","Luo, Zhe","32389785"],"journal":"J Infect","authors":["Su, Ying","Tu, Guo-Wei","Ju, Min-Jie","Yu, Shen-Ji","Zheng, Ji-Li","Ma, Guo-Guang","Liu, Kai","Ma, Jie-Fei","Yu, Kai-Huan","Xue, Yuan","Luo, Zhe"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32389785","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jinf.2020.05.007","keywords":["covid-19","crb-65","curb-65","community-acquired pneumonia","qsofa"],"topics":["Diagnosis"],"weight":1,"_version_":1666528580142628864,"score":9.490897,"similar":[{"pmid":32474039,"title":"Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19.","text":["Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19.","J Infect","Nguyen, Yann","Corre, Felix","Honsel, Vasco","Curac, Sonja","Zarrouk, Virginie","Fantin, Bruno","Galy, Adrien","32474039"],"journal":"J Infect","authors":["Nguyen, Yann","Corre, Felix","Honsel, Vasco","Curac, Sonja","Zarrouk, Virginie","Fantin, Bruno","Galy, Adrien"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474039","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jinf.2020.05.049","keywords":["covid-19","curb-65","outpatient care","risk factor"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668341932689981440,"score":63.957573},{"pmid":32427192,"pmcid":"PMC7232599","title":"[Statement of the Austrian Society of Pneumology (ASP)].","text":["[Statement of the Austrian Society of Pneumology (ASP)].","The COVID-19 pandemic is currently a challenge worldwide. In Austria, a crisis within the health care system has so far been avoided. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic. However, COVID-19-specific adjustments are useful. The treatment of patients with chronic lung diseases must be adapted during the pandemic, but must still be guaranteed.","Wien Klin Mag","Flick, H","Arns, B M","Bolitschek, J","Bucher, B","Cima, K","Gingrich, E","Handzhiev, S","Hochmair, M","Horak, F","Idzko, M","Jaksch, P","Kovacs, G","Kropfmuller, R","Lamprecht, B","Loffler-Ragg, J","Meilinger, M","Olschewski, H","Pfleger, A","Puchner, B","Puelacher, C","Prior, C","Rodriguez, P","Salzer, H","Schenk, P","Schindler, O","Stelzmuller, I","Strenger, V","Taubl, H","Urban, M","Wagner, M","Wimberger, F","Zacharasiewicz, A","Zwick, R H","Eber, E","32427192"],"abstract":["The COVID-19 pandemic is currently a challenge worldwide. In Austria, a crisis within the health care system has so far been avoided. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic. However, COVID-19-specific adjustments are useful. The treatment of patients with chronic lung diseases must be adapted during the pandemic, but must still be guaranteed."],"journal":"Wien Klin Mag","authors":["Flick, H","Arns, B M","Bolitschek, J","Bucher, B","Cima, K","Gingrich, E","Handzhiev, S","Hochmair, M","Horak, F","Idzko, M","Jaksch, P","Kovacs, G","Kropfmuller, R","Lamprecht, B","Loffler-Ragg, J","Meilinger, M","Olschewski, H","Pfleger, A","Puchner, B","Puelacher, C","Prior, C","Rodriguez, P","Salzer, H","Schenk, P","Schindler, O","Stelzmuller, I","Strenger, V","Taubl, H","Urban, M","Wagner, M","Wimberger, F","Zacharasiewicz, A","Zwick, R H","Eber, E"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427192","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s00740-020-00350-4","keywords":["ards","covid-19","chronic lung diseases","community-acquired pneumonia","sars-cov2"],"locations":["Austria"],"countries":["Austria"],"countries_codes":["AUT|Austria"],"topics":["Prevention"],"weight":1,"_version_":1667352728883429376,"score":54.65207},{"pmid":32032682,"pmcid":"PMC7102641","title":"Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses.","text":["Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses.","A zoonotic coronavirus, tentatively labeled as 2019-nCoV by the World Health Organization (WHO), has been identified as the causative agent of the viral pneumonia outbreak in Wuhan, China, at the end of 2019. Although 2019-nCoV can cause a severe respiratory illness like SARS and MERS, evidence from clinics suggested that 2019-nCoV is generally less pathogenic than SARS-CoV, and much less than MERS-CoV. The transmissibility of 2019-nCoV is still debated and needs to be further assessed. To avoid the 2019-nCoV outbreak turning into an epidemic or even a pandemic and to minimize the mortality rate, China activated emergency response procedures, but much remains to be learned about the features of the virus to refine the risk assessment and response. Here, the current knowledge in 2019-nCoV pathogenicity and transmissibility is summarized in comparison with several commonly known emerging viruses, and information urgently needed for a better control of the disease is highlighted.","Microbes Infect","Chen, Jieliang","32032682"],"abstract":["A zoonotic coronavirus, tentatively labeled as 2019-nCoV by the World Health Organization (WHO), has been identified as the causative agent of the viral pneumonia outbreak in Wuhan, China, at the end of 2019. Although 2019-nCoV can cause a severe respiratory illness like SARS and MERS, evidence from clinics suggested that 2019-nCoV is generally less pathogenic than SARS-CoV, and much less than MERS-CoV. The transmissibility of 2019-nCoV is still debated and needs to be further assessed. To avoid the 2019-nCoV outbreak turning into an epidemic or even a pandemic and to minimize the mortality rate, China activated emergency response procedures, but much remains to be learned about the features of the virus to refine the risk assessment and response. Here, the current knowledge in 2019-nCoV pathogenicity and transmissibility is summarized in comparison with several commonly known emerging viruses, and information urgently needed for a better control of the disease is highlighted."],"journal":"Microbes Infect","authors":["Chen, Jieliang"],"date":"2020-02-08T11:00:00Z","year":2020,"_id":"32032682","source":"PubMed","week":"20206|Feb 03 - Feb 09","doi":"10.1016/j.micinf.2020.01.004","keywords":["ace2","basic reproduction number (r(0))","case fatality rate","novel coronavirus infection","sars"],"locations":["Wuhan","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1666138493028401152,"score":43.328896},{"pmid":32035509,"pmcid":"PMC7154507","title":"Coronavirus epidemic: preparing for extracorporeal organ support in intensive care.","text":["Coronavirus epidemic: preparing for extracorporeal organ support in intensive care.","Lancet Respir Med","Ronco, Claudio","Navalesi, Paolo","Vincent, Jean Louis","32035509"],"journal":"Lancet Respir Med","authors":["Ronco, Claudio","Navalesi, Paolo","Vincent, Jean Louis"],"date":"2020-02-10T11:00:00Z","year":2020,"_id":"32035509","source":"PubMed","week":"20207|Feb 10 - Feb 16","doi":"10.1016/S2213-2600(20)30060-6","topics":["Treatment"],"weight":1,"_version_":1666138493021061123,"score":40.592407}]}